Punarnavine induces apoptosis in B16F-10 melanoma cells by inhibiting NF-κB signaling

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue 6, 2009, Pages 1031-1038

  Manu, Kanjoormana Aryan ^a   Kuttan, Girija ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

Apoptosis induction; B16F 10 melanoma cells; NF B inhibition; Punarnavine

Indexed keywords

ALKALOID; CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PUNARNAVINE;

ANIMAL; APOPTOSIS; ARTICLE; CELL CYCLE; DNA FRAGMENTATION; DOSE RESPONSE; DRUG EFFECT; EXPERIMENTAL MELANOMA; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NICK END LABELING; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

ALKALOIDS; ANIMALS; APOPTOSIS; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; GENES, P53; IN SITU NICK-END LABELING; MELANOMA, EXPERIMENTAL; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 77956630390     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Agarwal RR, Dutt SS. (1935). Chemical examination of Punarnava or Boerhaavia diffusa Linn. II. Isolation of an alkaloid punarnavine. Proc.acad. sci. United Provinces, Agra Audh. India, 5, 240-2. CAN 30:27236
2. Alnemri ES, Livingston DJ, Nicholson DW, et al. (1996). Human ICE/CED-3 protease nomenclature. Cell, 87, 171.
3. Angel P, Karin M. (1991). The role of Jun, Fos and the AP complex in cell proliferation and transformation. Biochim Biophys Acta, 1072, 129-157.
4. Banki K, Hutter E, Gonchoroff NJ, Perl A. (1999). Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling. J Immunol, 162, 1466-79.
5. Basu NK, Sharma SN. (1947). Investigations on Indian medicinal plants. Boerhaavia diffusa Linn. Quart J Pharm Pharmacol, 20, 38-42
6. Clarke PG, Clarke S. (1995) Historic apoptosis. Nature, 378, 230.
7. CSIR (1988). The Wealth of India: Raw Materials Vol. 7 B. CSIR, New Delhi, India, p174.
8. Donehower LA, Harvey M, Slagle BL, et al. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature, 356, 215-21.
9. Gilmore TD. (2006). Introduction to NF-κB: players, pathways, perceptive. Oncogene, 25, 6680-4.
10. Griffiths AJF, Miller JH, Suzuki DT, Lewontin RC, Gelbart WM. (2002). Intro to Genetic Analysis. An introduction to Genetic Analysis 7th ed., W.H. Freeman and Company, New York, pp 484, 647-669.
11. Huang C, Chen N, Ma WY, Dong Z. (1998). Vanadium induces AP-1 and NF-κB dependent transcription activity. Int J Oncol, 13, 711-715.
12. Huang C, Huang Y, Li J et al. (2002). Inhibition of benzo(a) pyrene diol-epoxide-induced transactivation of activator protein-1 and nuclear factor- κB by black raspberry extracts. Cancer Res, 63, 2206-2215.
13. Huppertz B, Frank HG, Kaufmann P. (1999).The apoptosis cascade-morphological and immunohistochemical methods for its visualization. Anat Embryol, 200, 1-18.
14. Janiak F, Leber B, Andrews DW. (1994). Assembly of Bcl-2 into microsomal and outer mitochondrial membranes. J Biol Chem, 269, 9842-9.
15. Karin M, Delhase M. (2000). The I kappa B kinase (IKK) and NF-κB: key elements of proinflammatory signaling. Semin Immunol, 12, 85-98.
16. Kawamura K, Sato N, Fukuda J, et al. (2003). Survivin acts as an antiapoptotic factor during the development of mouse preimplantation embryos. Dev Biol, 256, 331-41.
17. Kerr JF, Wyllie AH, Currie AR. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer, 26, 239-257.
18. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. (1997). The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science, 275, 1132-36.
19. Kothakota S, Azuma T, Reinhard C, et al. (1997). Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science, 278, 294-8.
20. Manu KA, Kuttan G. (2007). Effect of Punarnavine, an alkaloid from Boerhaavia diffusa, on cell-mediated immune responses and TIMP-1 in B16F-10 metastatic melanomabearing mice. Immunopharmacol Immunotoxicol, 29, 569-86.
21. Manu KA, Kuttan G. (2009a). Immunomodulatory activities of Punarnavine, an alkaloid from Boerhaavia diffusa. Immunopharmacol Immunotoxicol, 31, 377-87a.
22. Manu KA, Kuttan G. (2009b). Anti-metastatic potential of Punarnavine, an alkaloid from Boerhaavia diffusa.Linn. Immunobiology, 214, 245-55b.
23. Matta H, Eby MT, Gazdar AF, et al. (2002). Role of MRIT/cFLIP in protection against chemotherapy-induced apoptosis. Cancer Biol Ther, 1, 652-60.
24. McDonnell TJ, Deane N, Platt FM, et al. (1989). Bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell, 57, 79-88.
25. Miyashita T, Reed JC. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-9.
26. Moroni MC, Hickman ES, Lazzerini Denchi E, et al. (2001) Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol, 3, 552-8
27. Mukhopadhyay A, Banerjee S, Stafford LJ, et al. (2002). Curcumininduced suppression of cell proliferation correlates with downregulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene, 21, 8852-61.
28. Muller M, Wilder S, Bannasch D, et al. (1998) p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med, 188, 2033-45.
29. Nakano K, Vousden KH. (2001) PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell, 7, 683-94.
30. Oda E, Ohki R, Murasawa H, et al. (2000). Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science, 288, 1053-8.
31. Oda K, Arakawa H, Tanaka T, et al. (2000). p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell, 102, 8490-62.
32. Ogilvy S, et al. (1999). Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc Natl Acad Sci USA, 96, 14943-8.
33. Rayet B, Gelinas C. (1999). Aberrant rel/nfkb genes and activity in human cancer. Oncogene, 18, 6938-47.
34. Sakahira H, Enari M, Nagata S. (1998) Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature, 391, 96-99.
35. Sax JK, Fei P, Murphy ME, et al. (2002) BID regulation by p53 contributes to chemosensitivity. Nat Cell Biol, 4, 842-9.
36. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ. (1991). Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell, 67, 879-88.
37. Sethi S, Zafar R. (2003).Genus Boerhaavia. Ind J Natural Prod, 19, 3-10.
38. Shen Z, Peedikayil J, Olson GK, Seibert PD, Fang Y. (2002). Multiple transcription factor profiling by enzyme-linked immunoassay. Biotechniques, 32, 1168-77.
39. Silverman N, Maniatis T. (2001). NF- κB signaling pathways in mammalian and insect innate immunity. Genes Dev, 15, 2321-42.
40. Strasser A, Harris AW, Cory S. (1991). Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell, 67, 889-899.
41. Strasser A, Whittingham S, Vaux DL, et al. (1991). Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA, 88, 8661-5
42. Surange SR, Pendse GS. (1972). Pharmacognostic study of roots of Boerhaavia diffusa Willd.(punarnava). Journal of research in Indian medicine, 7, 1-5.
43. Susin SA, Lorenzo HK, Zamzami N, Mazzo I, Snow. BE, et al, (1999). Molecular characterization of mitochondrial apoptosis-inducing factor. Nature, 397, 441-46
44. Thompson CB. (1995). Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456-62.
45. Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT, Thompson CB. (1997). Bcl-XL regulates the membrane potential and volume homoestasis of mitochondira. Cell, 91
46. Vaux DL, Cory S, Adams, JM. (1988). Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-Myc to immortalize pre-B cells. Nature, 335, 440-2.
47. Vogelstein B, Lane D and Levine AJ. (2000). Surfing the p53 network. Nature, 408, 307-10.
48. Watson AJ. (1995). Review article: manipulation of cell death/the development of novel strategies for the treatment of gastrointestinal disease. Aliment Pharmacol Ther, 9, 215-26.
49. Wu GS, Burns TF, McDonald III ER, et al. (1997) KILLER/ DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet, 17, 141-3.
50. Xu Y. (2003) Regulation of p53 responses by post-translational modifications. Cell Death Differ, 10, 400-3.
51. Yang J, Liu XS, Bhalla K, et al. (1997). Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria bocked. Science, 275, 1129-32.
52. Zerbini LF, Wang Y, Cho JY, Libermann TA. (2003). Constitutive activation of nuclear factor- κB p50/p65 and Fra-1 and Jun-D essential for deregulated interleukin-6 expression in prostate cancer. Cancer Res, 63, 2206-15.
53. Zhong Y, Voll R, Ghosh S. (1998). Phophorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with thecoactivator CBP/p300. Mol Cell, 1, 29411-6.